The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled surviva
Similar stories
4 outlets
See how this story developed, hour by hour
FDA approves breakthrough pancreatic cancer drug
npr.org
27.08.2026
US drug agency approves breakthrough treatment for pancreatic cancer
bbc.co.uk
27.08.2026
FDA Approves Rasonque for Pancreatic Cancer: When It’s Available and Cost
newsweek.com
26.08.2026
FDA gives expedited approval to new groundbreaking pancreatic cancer drug
theguardian.com
26.08.2026